Free Trial

GSK (GSK) Insider Trading & Ownership

→ The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad)
Free GSK Stock Alerts
$40.88
-0.36 (-0.87%)
(As of 04/24/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

GSK (NYSE:GSK) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.00%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$392.06 M
Get GSK Insider Trade Alerts

Want to know when executives and insiders are buying or selling GSK stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GSK Insider Buying and Selling by Quarter

Ad WealthPress
The system that called 2023’s top 7 stocks is at it again…
Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.
Just follow this link here!

GSK Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/16/2023Tommy TubervilleU.S. Congress Member (R-AL)Sell$36.59$1,001 - $15,000
7/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$33.85$15,001 - $50,000
4/3/2023Tommy TubervilleU.S. Congress Member (R-AL)Buy$35.95$1,001 - $15,000
3/1/2023Virginia FoxxU.S. Congress Member (R-NC)Sell$34.26$50,001 - $100,000
8/16/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$35.26$1,001 - $15,000
8/10/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$38.30$15,001 - $50,000
8/9/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$40.03$1,001 - $15,000
8/5/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$40.57$15,001 - $50,000
7/12/2022Virginia FoxxU.S. Congress Member (R-NC)Sell$41.44$100,001 - $250,000
7/6/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$43.11$1,001 - $15,000
4/8/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$46.64$1,001 - $15,000
2/22/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$42.69$1,001 - $15,000
2/17/2022John H. RutherfordU.S. Congress Member (R-FL)Sell$43.32$1,001 - $15,000
1/14/2022Virginia FoxxU.S. Congress Member (R-NC)Buy$45.47$1,001 - $15,000
10/8/2021Virginia FoxxU.S. Congress Member (R-NC)Buy$38.71$1,001 - $15,000
7/9/2021Virginia FoxxU.S. Congress Member (R-NC)Buy$40.16$1,001 - $15,000
6/4/2021Katherine M. ClarkU.S. Congress Member (D-MA)Sell$38.90$1,001 - $15,000
6/4/2021Katherine M. ClarkU.S. Congress Member (D-MA)Sell$38.90$1,001 - $15,000
5/20/2021Plc GlaxosmithklineMajor ShareholderSell32,005,260$12.25$392,064,435.00  
(Data available from 1/1/2013 forward)

GSK Insider Trading Activity - Frequently Asked Questions

Who is on GSK's Insider Roster?

The list of insiders at GSK includes Plc Glaxosmithkline. Learn more on insiders at GSK.

What percentage of GSK stock is owned by insiders?

10.00% of GSK stock is owned by insiders. Learn more on GSK's insider holdings.

Which members of congress are trading GSK?

Tommy Tuberville (R-AL) and Daniel S. Goldman (D-NY) have sold shares of GSK in the last year totaling $40,500.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NYSE:GSK) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners
He Is Giving Away Bitcoin
Crypto Swap Profits
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
Emergency: Biden's $20 Trillion Mistake Could Cost YOU!
GoldenCrest Metals
The #1 Biotech Stock to Have on Your Radar in 2024…
Huge Alerts
Fed launches fourth dollar overhaul
Stansberry Research
The #1 Crypto for 2024
InvestorPlace